We are live on ! Find out more
IMA

ImageneBio Inc
IMA

55 hedge funds and large institutions have $42.7M invested in ImageneBio Inc in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

2% more funds holding

Funds holding: 54 → 55 (+1)

0.41% less ownership

Funds ownership: 5.6% → 5.2% (-0.41%)

12% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 17

33% less capital invested

Capital invested by funds: $63.9M → $42.7M (-$21.2M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
10
Increased
15
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BOCH
Blue Owl Capital Holdings
New York
+$2.94M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.18M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$694K
4
AI
Acuitas Investments
Washington
+$604K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$396K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.34M
2
AG
Artal Group
Luxembourg
-$1.97M
3
LCM
Laurion Capital Management
New York
-$734K
4
VPC
Vestal Point Capital
New York
-$636K
5
VVA
Vida Ventures Advisors
Massachusetts
-$444K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$7.13M – – –
BI
2
BVF Inc
California
$6.77M – – –
BOCH
3
Blue Owl Capital Holdings
New York
$5.53M +$2.94M +161,459 +99%
O
4
OrbiMed
New York
$5.03M – – –
OFM
5
Omega Fund Management
Massachusetts
$3.19M – – –
BlackRock
6
BlackRock
New York
$2.6M -$44.6K -2,450 -2%
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.18M +$11.1K +610 +0.5%
Verition Fund Management
8
Verition Fund Management
Connecticut
$1.61M -$285K -15,643 -14%
Renaissance Technologies
9
Renaissance Technologies
New York
$1.1M +$1.18M +64,717 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$848K +$103K +5,659 +13%
NMC
11
NEA Management Company
Maryland
$809K – – –
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$729K +$694K +38,104 +814%
State Street
13
State Street
Massachusetts
$685K +$109K +5,991 +18%
AI
14
Acuitas Investments
Washington
$565K +$604K +33,146 New
SI
15
Sofinnova Investments
California
$543K +$29K +1,595 +5%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$409K – – –
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$400K +$396K +21,755 +1,202%
Two Sigma Investments
18
Two Sigma Investments
New York
$345K +$291K +16,003 +377%
Northern Trust
19
Northern Trust
Illinois
$333K -$6.54K -359 -2%
Barclays
20
Barclays
United Kingdom
$279K -$72.6K -3,986 -20%
Citadel Advisors
21
Citadel Advisors
Florida
$226K -$29.1K -1,597 -11%
Marshall Wace
22
Marshall Wace
United Kingdom
$126K +$135K +7,391 New
Charles Schwab
23
Charles Schwab
California
$122K – – –
BCM
24
Bridgeway Capital Management
Texas
$117K -$93K -5,105 -43%
Two Sigma Advisers
25
Two Sigma Advisers
New York
$113K +$121K +6,658 New
1
2 3

IMA Hedge Fund Activity: Q1 2024 in Review

55 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2024, worth a combined $42.7M — down 33% from $63.9M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new IMA positions and 8 closed out — a net gain of 2 holders — while 15 added to existing stakes and 17 trimmed.

The largest buyer was Blue Owl Capital Holdings, adding an estimated $2.94M. The largest seller was Fidelity Investments, cutting an estimated $6.34M.

  • 55 institutional investors held ImageneBio Inc (IMA) as of Q1 2024, up from 54 in Q4 2023.
  • Funds reported $42.7M of ImageneBio Inc stock for Q1 2024, down 33% quarter-over-quarter.
  • 10 funds opened new ImageneBio Inc positions in Q1 2024 and 8 closed out, a net change of +2 holders.
  • The largest ImageneBio Inc buyer in Q1 2024 was Blue Owl Capital Holdings, an estimated $2.94M added.
  • The largest ImageneBio Inc seller in Q1 2024 was Fidelity Investments, an estimated $6.34M sold.

Based on aggregated 13F filings for Q1 2024.